The US Food and Drug Administration has approved Journavx, also known as suzetrigine 50 milligram oral tablets—a first-in-class non-opioid analgesic—to treat moderate to severe acute pain in adults.
This optical illusion challenges viewers to find a hidden '3' among a pattern of golden balloon-like symbols. The brain’s tendency to recognize uniformity makes spotting the anomaly difficult. Based ...